Minoo N Kavarana1, Rupak Mukherjee2, Shaina R Eckhouse2, William F Rawls2, Christina Logdon3, Robert E Stroud2, Risha K Patel2, Elizabeth K Nadeau2, Francis G Spinale3, Eric M Graham4, Geoffrey A Forbus4, Scott M Bradley2, John S Ikonomidis2, Jeffrey A Jones5. 1. Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina. Electronic address: kavarana@musc.edu. 2. Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina. 3. University of South Carolina School of Medicine, Columbia, South Carolina. 4. Division of Pediatric Cardiology, Medical University of South Carolina, Charleston, South Carolina. 5. Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina; Division of Pediatric Cardiology, Medical University of South Carolina, Charleston, South Carolina.
Abstract
BACKGROUND: Longevity of the superior cavopulmonary connection (SCPC) is limited by the development of pulmonary arteriovenous malformations (PAVM). The goal of this study was to determine whether phenotypic changes in pulmonary artery endothelial cells (PAEC) that favor angiogenesis occur with PAVM formation. METHODS: A superior vena cava to right pulmonary artery connection was constructed in 5 pigs. Pulmonary arteries were harvested at 6 to 8 weeks after surgery to establish cultures of PAEC and smooth muscle cells, to determine cell proliferation, gene expression, and tubule formation. Abundance of proteins related to angiogenesis was measured in lung tissue. RESULTS: Contrast echocardiography revealed right-to-left shunting, consistent with PAVM formation. While the proliferation of smooth muscle cells from the right pulmonary artery (shunted side) and left pulmonary artery (nonshunted side) were similar, right PAEC proliferation was significantly higher. Expression profiles of genes encoding cellular signaling proteins were higher in PAECs from the right pulmonary artery versus left pulmonary artery. Protein abundance of angiopoietin-1, and Tie-2 (angiopoietin receptor) were increased in the right lung (both p < 0.05). Tubule formation was increased in endothelial cells from the right pulmonary artery compared with the left pulmonary artery (404 ± 16 versus 199 ± 71 tubules/mm(2), respectively; p < 0.05). CONCLUSIONS: These findings demonstrate that PAVMs developed in a clinically relevant animal model of SCPC concomitantly with differential changes in PAEC proliferative ability and phenotype. Moreover, there was a significant increase in the angiopoietin/Tie-2 complex in the right lung, which may provide novel therapeutic targets to attenuate PAVM formation after a SCPC.
BACKGROUND: Longevity of the superior cavopulmonary connection (SCPC) is limited by the development of pulmonary arteriovenous malformations (PAVM). The goal of this study was to determine whether phenotypic changes in pulmonary artery endothelial cells (PAEC) that favor angiogenesis occur with PAVM formation. METHODS: A superior vena cava to right pulmonary artery connection was constructed in 5 pigs. Pulmonary arteries were harvested at 6 to 8 weeks after surgery to establish cultures of PAEC and smooth muscle cells, to determine cell proliferation, gene expression, and tubule formation. Abundance of proteins related to angiogenesis was measured in lung tissue. RESULTS: Contrast echocardiography revealed right-to-left shunting, consistent with PAVM formation. While the proliferation of smooth muscle cells from the right pulmonary artery (shunted side) and left pulmonary artery (nonshunted side) were similar, right PAEC proliferation was significantly higher. Expression profiles of genes encoding cellular signaling proteins were higher in PAECs from the right pulmonary artery versus left pulmonary artery. Protein abundance of angiopoietin-1, and Tie-2 (angiopoietin receptor) were increased in the right lung (both p < 0.05). Tubule formation was increased in endothelial cells from the right pulmonary artery compared with the left pulmonary artery (404 ± 16 versus 199 ± 71 tubules/mm(2), respectively; p < 0.05). CONCLUSIONS: These findings demonstrate that PAVMs developed in a clinically relevant animal model of SCPC concomitantly with differential changes in PAEC proliferative ability and phenotype. Moreover, there was a significant increase in the angiopoietin/Tie-2 complex in the right lung, which may provide novel therapeutic targets to attenuate PAVM formation after a SCPC.
Authors: Sunil P Malhotra; V Mohan Reddy; Stephan Thelitz; You-Ping He; Frank L Hanley; Sam Suleman; R Kirk Riemer Journal: J Thorac Cardiovasc Surg Date: 2002-04 Impact factor: 5.209
Authors: Sunil P Malhotra; V Mohan Reddy; Stephan Thelitz; You-Ping He; D Michael McMullan; Frank L Hanley; R Kirk Riemer Journal: J Thorac Cardiovasc Surg Date: 2002-09 Impact factor: 5.209
Authors: J M Laberge; M L Brandt; P Lebecque; D Moulin; F Veykemans; K Paradis; L Pelletier; J Lacroix; H Blanchard; J de Ville de Goyet Journal: Transplantation Date: 1992-05 Impact factor: 4.939
Authors: Rob J Dekker; Simone van Soest; Ruud D Fontijn; Sonia Salamanca; Philip G de Groot; Ed VanBavel; Hans Pannekoek; Anton J G Horrevoets Journal: Blood Date: 2002-09-01 Impact factor: 22.113
Authors: Eric M Wilson; Sina L Moainie; Julia M Baskin; Abigail S Lowry; Anne M Deschamps; Rupak Mukherjee; T Sloane Guy; Martin G St John-Sutton; Joseph H Gorman; L Henry Edmunds; Robert C Gorman; Francis G Spinale Journal: Circulation Date: 2003-05-27 Impact factor: 29.690
Authors: Minoo N Kavarana; Jeffrey A Jones; Robert E Stroud; Scott M Bradley; John S Ikonomidis; Rupak Mukherjee Journal: Expert Rev Cardiovasc Ther Date: 2014-04-23
Authors: Andrew D Spearman; Ankan Gupta; Amy Y Pan; Emily I Gronseth; Karthikeyan Thirugnanam; Todd M Gudausky; Susan R Foerster; Ramani Ramchandran Journal: Semin Thorac Cardiovasc Surg Date: 2020-05-07